Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and co-construction of a therapeutic patient education program for albinism.
Dufresne H, de Longcamp A, Compain S, Morice-Picard F, Deladrière E, Bekel L, Godot C, Rateaux M, Godeau M, Jouanne B, Bodemer C, Bremond-Gignac D, Robert MP, Hadj-Rabia S. Dufresne H, et al. Among authors: godot c. Ann Dermatol Venereol. 2021 Dec;148(4):246-250. doi: 10.1016/j.annder.2021.03.005. Epub 2021 Jun 30. Ann Dermatol Venereol. 2021. PMID: 34217528
Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.
Beltrand J, Baptiste A, Busiah K, Bouazza N, Godot C, Boucheron A, Djerada Z, Gozalo C, Berdugo M, Tréluyer JM, Elie C, Polak M; GLID-KIR study group. Beltrand J, et al. Among authors: godot c. Pediatr Diabetes. 2019 May;20(3):246-254. doi: 10.1111/pedi.12823. Epub 2019 Feb 21. Pediatr Diabetes. 2019. PMID: 30684309 Clinical Trial.
Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
Kariyawasam D, Morin C, Casteels K, Le Tallec C, Sfez A, Godot C, Huneker E, Garrec N, Benhamou PY, Polak M, Charpentier G, Franc S, Beltrand J. Kariyawasam D, et al. Among authors: godot c. Lancet Digit Health. 2022 Mar;4(3):e158-e168. doi: 10.1016/S2589-7500(21)00271-5. Lancet Digit Health. 2022. PMID: 35216750 Free article. Clinical Trial.
Mitchell-Riley Syndrome: Improving Clinical Outcomes and Searching for Functional Impact of RFX-6 Mutations.
Passone CGB, Vermillac G, Staels W, Besancon A, Kariyawasam D, Godot C, Lambe C, Talbotec C, Girard M, Chardot C, Berteloot L, Hachem T, Lapillonne A, Poidvin A, Storey C, Neve M, Stan C, Dugelay E, Fauret-Amsellem AL, Capri Y, Cavé H, Ybarra M, Chandra V, Scharfmann R, Bismuth E, Polak M, Carel JC, Pigneur B, Beltrand J. Passone CGB, et al. Among authors: godot c. Front Endocrinol (Lausanne). 2022 Jun 22;13:802351. doi: 10.3389/fendo.2022.802351. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35813646 Free PMC article.
Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function Mutation.
Sarfati E, Hadjadj J, Fusaro M, Klifa R, Grimaud M, Berteloot L, Hadchouel A, Godot C, Stolzenberg MC, Frémond ML, Pressiat C, Molina T, Fischer A, Picard C, Renolleau S, Rieux-Laucat F, Blanche S, Neven B. Sarfati E, et al. Among authors: godot c. J Clin Immunol. 2021 May;41(4):807-810. doi: 10.1007/s10875-020-00914-3. Epub 2021 Jan 11. J Clin Immunol. 2021. PMID: 33428086 No abstract available.
14 results